Insider trades
Michael J. McElhaugh, CEO of Arbutus Biopharma ABUS, has filed 0 purchases and 2 sales on the open market. The latest trade was on 25/02/14.
Michael J. McElhaugh
Interim President & CEO
- Company
- Arbutus Biopharma ABUS
- First filing
- 23/02/03
- Trades
- 8 trades
- Buys / sales
- 0 / 2
- 12-month net buying
- No record
- Last trade
- 25/02/14
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 25/02/04 | 25/02/05 | 23,790 sh | $3.28 | $78,031.2 | −1.6% | |
| Open-market sale10b5-1 plan | 24/02/02 | 24/02/05 | 10,164 sh | $2.31 | $23,478.84 | −0.7% |